SPDR S&P Pharmaceuticals shares owned by Citadel Advisors
Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in SPDR S&P Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including SPDR S&P Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in SPDR S&P Pharmaceuticals by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $275k | 5.7k | 47.94 |
| 2025-06-30 | $1.5M | 38k | 40.58 |
| 2025-03-31 | $409k | 9.3k | 43.80 |
| 2024-12-31 | $2.7M | 63k | 42.99 |
| 2024-09-30 | $1.6M | 36k | 44.36 |
| 2024-06-30 | $1.0M | 26k | 39.78 |
| 2024-03-31 | $2.3M | 53k | 43.13 |
| 2023-12-31 | $606k | 15k | 41.62 |
| 2023-09-30 | $1.8M | 47k | 39.75 |
| 2023-06-30 | $2.1M | 52k | 40.99 |
| 2023-03-31 | $2.0M | 50k | 41.01 |
| 2022-12-31 | $217k | 5.3k | 40.95 |
| 2022-03-31 | $416k | 9.2k | 45.22 |
| 2021-12-31 | $1.7M | 37k | 46.16 |
| 2021-09-30 | $805k | 17k | 47.41 |
| 2021-06-30 | $1.8M | 36k | 51.82 |
| 2021-03-31 | $734k | 15k | 50.35 |
| 2020-09-30 | $636k | 15k | 43.46 |
| 2020-03-31 | $1.0M | 29k | 36.08 |
| 2019-12-31 | $1.9M | 42k | 45.68 |
| 2019-09-30 | $1.2M | 34k | 35.58 |
| 2019-06-30 | $706k | 18k | 39.84 |
| 2018-12-31 | $560k | 15k | 36.65 |
| 2018-06-30 | $1.8M | 42k | 43.02 |
| 2018-03-31 | $1.4M | 33k | 41.85 |
| 2017-12-31 | $989k | 23k | 43.51 |
| 2017-09-30 | $1.2M | 27k | 42.55 |
| 2017-03-31 | $1.8M | 43k | 41.82 |
| 2016-12-31 | $1.7M | 44k | 39.10 |
| 2016-09-30 | $1.9M | 42k | 44.19 |
| 2016-03-31 | $778k | 19k | 40.26 |
| 2015-12-31 | $2.3M | 45k | 51.20 |
| 2015-09-30 | $1.3M | 28k | 46.92 |
| 2015-03-31 | $226k | 1.8k | 123.43 |
| 2014-03-31 | $985k | 11k | 93.63 |